Gotham Asset Management’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-135,152
| Closed | -$3.94M | – | 1468 |
|
|
2024
Q2 | $3.94M | Buy |
135,152
+124,079
| +1,121% | +$3.68M | 0.05% | 492 |
|
|
2024
Q1 | $393K | Buy |
11,073
+30
| +0.3% | +$1.2K | 0.01% | 1127 |
|
|
2023
Q4 | $481K | Sell |
11,043
-19,048
| -63% | -$750K | 0.01% | 1002 |
|
|
2023
Q3 | $1.15M | Buy |
30,091
+2,302
| +8% | +$96.8K | 0.02% | 730 |
|
|
2023
Q2 | $1.14M | Buy |
27,789
+680
| +3% | +$32.7K | 0.02% | 729 |
|
|
2023
Q1 | $1.56M | Buy |
27,109
+12,150
| +81% | +$685K | 0.04% | 595 |
|
|
2022
Q4 | $839K | Buy |
14,959
+9,749
| +187% | +$496K | 0.02% | 744 |
|
|
2022
Q3 | $221K | Buy |
+5,210
| New | +$267K | 0.01% | 1064 |
|
|
2022
Q2 | – | Sell |
-20,412
| Closed | -$1.31M | – | 1178 |
|
|
2022
Q1 | $1.31M | Sell |
20,412
-24,251
| -54% | -$1.6M | 0.04% | 480 |
|
|
2021
Q4 | $2.99M | Buy |
44,663
+19,016
| +74% | +$1.29M | 0.1% | 260 |
|
|
2021
Q3 | $1.76M | Buy |
25,647
+20,062
| +359% | +$1.42M | 0.07% | 334 |
|
|
2021
Q2 | $381K | Buy |
+5,585
| New | +$395K | 0.02% | 762 |
|
|
2020
Q3 | – | Sell |
-5,555
| Closed | -$261K | – | 1082 |
|
|
2020
Q2 | $261K | Sell |
5,555
-33,006
| -86% | -$1.62M | 0.01% | 891 |
|
|
2020
Q1 | $1.72M | Buy |
38,561
+14,438
| +60% | +$758K | 0.05% | 432 |
|
|
2019
Q4 | $1.41M | Sell |
24,123
-2,620
| -10% | -$156K | 0.03% | 552 |
|
|
2019
Q3 | $1.61M | Sell |
26,743
-23,590
| -47% | -$1.41M | 0.03% | 491 |
|
|
2019
Q2 | $2.81M | Sell |
50,333
-63,336
| -56% | -$3.26M | 0.04% | 432 |
|
|
2019
Q1 | $6.33M | Buy |
113,669
+6,450
| +6% | +$329K | 0.09% | 294 |
|
|
2018
Q4 | $4.84M | Buy |
+107,219
| New | +$5.88M | 0.08% | 342 |
|
|
2018
Q1 | – | Sell |
-72,147
| Closed | -$3.45M | – | 999 |
|
|
2017
Q4 | $3.45M | Buy |
+72,147
| New | +$3.53M | 0.05% | 411 |
|
|
2017
Q2 | – | Sell |
-34,783
| Closed | -$1.47M | – | 1023 |
|
|
2017
Q1 | $1.47M | Buy |
34,783
+11,375
| +49% | +$486K | 0.02% | 602 |
|
|
2016
Q4 | $1M | Buy |
+23,408
| New | +$951K | 0.01% | 622 |
|
|
2015
Q4 | – | Sell |
-186,682
| Closed | -$5.56M | – | 917 |
|
|
2015
Q3 | $5.56M | Buy |
186,682
+153,926
| +470% | +$4.81M | 0.05% | 408 |
|
|
2015
Q2 | $902K | Buy |
+32,756
| New | +$873K | 0.01% | 650 |
|
|
2015
Q1 | – | Sell |
-44,156
| Closed | -$979K | – | 957 |
|
|
2014
Q4 | $979K | Sell |
44,156
-266,548
| -86% | -$5.4M | 0.01% | 628 |
|
|
2014
Q3 | $6.3M | Buy |
+310,704
| New | +$6.18M | 0.06% | 361 |
|
Other funds holding IART
SHCM
Gotham Asset Management's IART Position: Q3 2024 in Review
Gotham Asset Management sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 135,152 shares — an estimated $3.94M sold.
Gotham Asset Management first reported a position in IART in Q3 2014 and held it in 26 quarters. The position peaked at $6.33M in Q1 2019. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.
- Gotham Asset Management reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
- Gotham Asset Management sold 135,152 Integra LifeSciences shares in Q3 2024, an estimated $3.94M.
- Gotham Asset Management first reported a position in Integra LifeSciences in Q3 2014 and held it in 26 quarters.
- Gotham Asset Management's Integra LifeSciences position peaked at $6.33M in Q1 2019.
- 225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.
Based on Gotham Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.